Trieu Vuong

Executive buyer

Director, CHAIRMAN AND CEO, 10% Owner · Oncotelic Therapeutics, Inc.

Every open-market stock purchase Trieu Vuong has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where how the prices paid compare to where the stock trades now.

Total bought

$23.5K

Open-market buys

Companies

Last buy

Oct 29, 2026

Where the buys stand today

OTLC
Oncotelic Therapeutics, Inc.
2 purchases totalling $23.5K at an average of $0.02 per share. See all insider buying in OTLC →
Avg price paid
$0.02
Latest price
—
Market cap
Unknown

All reported buys

Date	Ticker	Shares	Price	Value	Filing
Oct 29, 2026	OTLC	1,044,990	$0.02	$17.8K	SEC ↗
Oct 28, 2026	OTLC	312,000	$0.02	$5.8K	SEC ↗

Follow new qualifying clusters involving Trieu Vuong or other insiders

Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.

Start a trial See pricing

About this data

Figures are parsed from Trieu Vuong's Form 4 filings on SEC EDGAR (CIK 1587074) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.